chr7-2913393-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_032415.7(CARD11):c.2913C>T(p.Cys971Cys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000634 in 1,612,090 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0031 ( 3 hom., cov: 32)
Exomes 𝑓: 0.00038 ( 5 hom. )
Consequence
CARD11
NM_032415.7 synonymous
NM_032415.7 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0470
Publications
3 publications found
Genes affected
CARD11 (HGNC:16393): (caspase recruitment domain family member 11) The protein encoded by this gene belongs to the membrane-associated guanylate kinase (MAGUK) family, a class of proteins that functions as molecular scaffolds for the assembly of multiprotein complexes at specialized regions of the plasma membrane. This protein is also a member of the CARD protein family, which is defined by carrying a characteristic caspase-associated recruitment domain (CARD). This protein has a domain structure similar to that of CARD14 protein. The CARD domains of both proteins have been shown to specifically interact with BCL10, a protein known to function as a positive regulator of cell apoptosis and NF-kappaB activation. When expressed in cells, this protein activated NF-kappaB and induced the phosphorylation of BCL10. [provided by RefSeq, Jul 2008]
CARD11 Gene-Disease associations (from GenCC):
- BENTA diseaseInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, Ambry Genetics
- immunodeficiency 11b with atopic dermatitisInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp, Ambry Genetics
- severe combined immunodeficiency due to CARD11 deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen, Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 7-2913393-G-A is Benign according to our data. Variant chr7-2913393-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 540977.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.047 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00309 (471/152288) while in subpopulation AFR AF = 0.0102 (426/41574). AF 95% confidence interval is 0.00944. There are 3 homozygotes in GnomAd4. There are 224 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AD,AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CARD11 | NM_032415.7 | c.2913C>T | p.Cys971Cys | synonymous_variant | Exon 22 of 25 | ENST00000396946.9 | NP_115791.3 | |
| CARD11 | NM_001324281.3 | c.2913C>T | p.Cys971Cys | synonymous_variant | Exon 23 of 26 | NP_001311210.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CARD11 | ENST00000396946.9 | c.2913C>T | p.Cys971Cys | synonymous_variant | Exon 22 of 25 | 1 | NM_032415.7 | ENSP00000380150.4 | ||
| CARD11 | ENST00000698637.1 | n.4023C>T | non_coding_transcript_exon_variant | Exon 21 of 24 | ||||||
| CARD11 | ENST00000698652.1 | n.1869C>T | non_coding_transcript_exon_variant | Exon 5 of 8 |
Frequencies
GnomAD3 genomes AF: 0.00309 AC: 470AN: 152170Hom.: 3 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
470
AN:
152170
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000935 AC: 233AN: 249166 AF XY: 0.000674 show subpopulations
GnomAD2 exomes
AF:
AC:
233
AN:
249166
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000377 AC: 551AN: 1459802Hom.: 5 Cov.: 32 AF XY: 0.000362 AC XY: 263AN XY: 726166 show subpopulations
GnomAD4 exome
AF:
AC:
551
AN:
1459802
Hom.:
Cov.:
32
AF XY:
AC XY:
263
AN XY:
726166
show subpopulations
African (AFR)
AF:
AC:
382
AN:
33478
American (AMR)
AF:
AC:
23
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
26124
East Asian (EAS)
AF:
AC:
2
AN:
39696
South Asian (SAS)
AF:
AC:
2
AN:
86256
European-Finnish (FIN)
AF:
AC:
40
AN:
51470
Middle Eastern (MID)
AF:
AC:
6
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
32
AN:
1111922
Other (OTH)
AF:
AC:
63
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
31
62
92
123
154
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00309 AC: 471AN: 152288Hom.: 3 Cov.: 32 AF XY: 0.00301 AC XY: 224AN XY: 74454 show subpopulations
GnomAD4 genome
AF:
AC:
471
AN:
152288
Hom.:
Cov.:
32
AF XY:
AC XY:
224
AN XY:
74454
show subpopulations
African (AFR)
AF:
AC:
426
AN:
41574
American (AMR)
AF:
AC:
24
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
1
AN:
5166
South Asian (SAS)
AF:
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
AC:
14
AN:
10628
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3
AN:
68008
Other (OTH)
AF:
AC:
2
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
25
50
76
101
126
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Dec 14, 2022
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Severe combined immunodeficiency due to CARD11 deficiency;C4551967:BENTA disease Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.